# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Tevogen Bio Holdings (NASDAQ:TVGN) reported quarterly losses of $(0.26) per share. This is unchanged from the same period last ...
Tevogen shares are rising Monday after the company secured up to $50 million of financing from an existing investor aimed at su...
GME: 46% | GameStop shares are trading higher amid possible retail investor interest following a social media post by Roaring K...
Supports expansion of Tevogen's ExacTcell™ platform toward additional clinical trials Bolsters a financial path to positive...